Response BiomedicalResponse BiomedicalResponse Biomedical
Response Biomedical Response Biomedical
Response Biomedical Response Biomedical
Response Biomedical
Response Biomedical
Response Biomedical
Response Biomedical
Response Biomedical
Response Biomedical
Response Biomedical Phone number call toll-free in North America 1.888.591.5577  outside North America call +1.604.456.6010
Newsroom
Response BiomedicalResponse BiomedicalResponse BiomedicalNewsroom
Response BiomedicalResponse BiomedicalNews Releases
Response BiomedicalResponse BiomedicalEvents Calendar
Response BiomedicalResponse BiomedicalPress Kit
Response Biomedical

Latest News 2008


 
Viewing PDF documents requires PDF Adobe Acrobat Reader, which may be downloaded for free.
 

 


Response Biomedical Announces Change of Executives
Newswire.ca    PDF
 


Response Biomedical Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
Newswire.ca    PDF
 


Response Biomedical Announces Third Quarter Results
Newswire.ca    PDF
 


Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
Newswire.ca    PDF
 


Response Biomedical Closes $5.1 Million Financing
Newswire.ca    PDF
 


Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference
Newswire.ca    PDF
 


Response Biomedical Completes Initial Closing of an expected $5.0 Million Financing
Newswire.ca    PDF
 


Response Biomedical Announces Insider Participation in Current Financing
Newswire.ca    PDF
 


Response Biomedical Announces $5.5 Million Financing Terms Amended
Newswire.ca    PDF
 


Response Biomedical Announces $5.5 Million Financing
Newswire.ca    PDF
 


Response Biomedical Corporation Announces Second Quarter Results
Newswire.ca    PDF
 


Response Biomedical Receives US FDA Clearance for RAMP® NT-proBNP Test for Diagnosis of Heart Failure
Newswire.ca    PDF
 


Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
Newswire.ca    PDF
 


Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
Newswire.ca    PDF
 


Response Biomedical Corporation Announces First Quarter Results
Newswire.ca    PDF
 


Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Influenza A+B Test
Newswire.ca    PDF
 


Response Biomedical Corporation Reports 2007 Financial Results
Newswire.ca    PDF
 


Response Biomedical Corporation Moves to New Facility
Newswire.ca    PDF
 
 
 
 
 
 
Website By North of Paris
Copyright © 2010 Response Biomedical Corporation